These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 658993)

  • 1. Prevalence of neutralizing antibodies against adenoviruses at Lucknow.
    Mathur A; Singh G; Singh UK; Mehrotra RM; Chaturvedi UC
    Indian J Med Res; 1978 Jan; 67():19-26. PubMed ID: 658993
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines.
    Appaiahgari MB; Pandey RM; Vrati S
    Clin Vaccine Immunol; 2007 Aug; 14(8):1053-5. PubMed ID: 17596429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Seroepidemiological study of conjunctivitis related adenoviruses].
    Aoki K; Sawada H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):181-6. PubMed ID: 3037868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Infection rate with adenivirus 1 to 39 in infants and adults].
    Fatz W; Wigand R
    Immun Infekt; 1985 May; 13(3):108-12. PubMed ID: 2408993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frequency of adenovirus group complement-specific antibodies in children].
    Söyletir G; Us D; Cerikcioğlu N; Babacan F
    Mikrobiyol Bul; 1990 Jan; 24(1):16-9. PubMed ID: 2283960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of adenovirus types 3 and 7 antibodies in Singapore.
    Nishio O; Matsui K; Goh KT; Matsunaga Y; Inouye S
    Jpn J Infect Dis; 2001 Jun; 54(3):128-9. PubMed ID: 11544409
    [No Abstract]   [Full Text] [Related]  

  • 7. The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines.
    Pilankatta R; Chawla T; Khanna N; Swaminathan S
    J Med Virol; 2010 Mar; 82(3):407-14. PubMed ID: 20087930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of infection with rotavirus and enteric adenoviruses among children in Tanzania.
    Mhalu FS; Myrmel H; Msengi A; Haukenes G
    NIPH Ann; 1988 Jun; 11(1):3-7. PubMed ID: 2841626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological diagnosis of adenovirus conjunctivitis].
    Isobe K; Aoki K; Ohno S
    Nippon Ganka Gakkai Zasshi; 1993 May; 97(5):610-3. PubMed ID: 8337965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa.
    Thorner AR; Vogels R; Kaspers J; Weverling GJ; Holterman L; Lemckert AA; Dilraj A; McNally LM; Jeena PM; Jepsen S; Abbink P; Nanda A; Swanson PE; Bates AT; O'Brien KL; Havenga MJ; Goudsmit J; Barouch DH
    J Clin Microbiol; 2006 Oct; 44(10):3781-3. PubMed ID: 17021110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors.
    Piedra PA; Poveda GA; Ramsey B; McCoy K; Hiatt PW
    Pediatrics; 1998 Jun; 101(6):1013-9. PubMed ID: 9606228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-36 and obesity.
    Atkinson RL
    Pediatr Obes; 2012 Apr; 7(2):e18-9. PubMed ID: 22434760
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibodies to enteric adenovirus (species 40 and 41) in the sera of children, young adults and the elderly].
    Araki K
    Uirusu; 1986 Dec; 36(2):263-71. PubMed ID: 3031877
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to 'human adenovirus-36 and childhood obesity'.
    Goossens VJ; Bruggeman CA
    Pediatr Obes; 2012 Apr; 7(2):e19-20. PubMed ID: 22434761
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of antibodies against enteroviruses in the populations of Lucknow.
    Agarwal SK; Kapoor AK; Mathur A; Mehrota RM; Chaturvedi UC
    Indian J Med Res; 1973 Dec; 61(12):1799-809. PubMed ID: 4362509
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to enteric adenoviruses (Ad40 and Ad41) in sera from Iranian children.
    Saderi H; Roustai MH; Sabahi F
    J Clin Virol; 2000 Apr; 16(2):145-7. PubMed ID: 10720819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials.
    Mast TC; Kierstead L; Gupta SB; Nikas AA; Kallas EG; Novitsky V; Mbewe B; Pitisuttithum P; Schechter M; Vardas E; Wolfe ND; Aste-Amezaga M; Casimiro DR; Coplan P; Straus WL; Shiver JW
    Vaccine; 2010 Jan; 28(4):950-7. PubMed ID: 19925902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to fastidious faecal adenoviruses (species 40 and 41) in sera from children.
    Kidd AH; Banatvala JE; de Jong JC
    J Med Virol; 1983; 11(4):333-41. PubMed ID: 6308143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients.
    Heemskerk B; Lankester AC; van Vreeswijk T; Beersma MF; Claas EC; Veltrop-Duits LA; Kroes AC; Vossen JM; Schilham MW; van Tol MJ
    J Infect Dis; 2005 Feb; 191(4):520-30. PubMed ID: 15655775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.